About clinical trials
Benefits of clinical trials
Phase III clinical trials offer additional support and monitoring, access to cutting-edge research, and the potential to improve patient outcomes and advance science.
- In a recent comprehensive examination of trial outcomes from a large set of cancer treatment trials, participants in trials were found to have better outcomes than non-participating patients in the first year after diagnosis1
- Participants receive extensive support throughout the trial, including close monitoring, access to necessary laboratory/diagnostic tests, and ongoing medical care and counseling2
- More than 80% of patients are eligible for clinical trials based on inclusion and exclusion criteria1
How to refer
Identifying trial-eligible patients
Use the Trial Finder to determine whether a patient is eligible for a particular clinical trial based on disease stage, biomarkers, and treatment history.
Important information about clinical trials
Addressing perceptions and misconceptions
Some patients may have misconceptions about clinical trials due to misinformation, or lack of personal experience or knowledge. Learn the accurate information to debunk common perceptions that patients might have about clinical trials. Whether their concerns are about placebos, safety, or eligibility, we have the tools to help you provide clear, factual answers.
References
- American Cancer Society Cancer Action Network. Barriers to patient enrollment in therapeutic clinical trials for cancer: a landscape report. Updated April 11, 2018. Accessed November 14, 2024. https://www.fightcancer.org/sites/default/files/National%20Documents/Clinical-Trials-Landscape-Report.pdf
- National Institutes of Health. NIH clinical research trials and you: the basics. Updated October 3, 2022. Accessed November 14, 2024. https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics
Your Privacy Choices
